Glyco-optimization and production
of recombinant proteins
SiaMed’Xpress provides design, engineering and early stage production of any glycoprotein of interest for human or veterinary use. Post-production sialylation may be also envisaged.
Glycosylation-specific antibodies
Antibodies frequently show difficulties to bind glycoproteins of recombinant origin. SiaMed’Xpress has developed strategies to overcome these limitations.
Diagnostic tests
Siamed’Xpress offers innovative immunoassays based on recombinant standard on a molar basis to fully comply with new regulatory certification.
Glycotechnologies
SiaMed’Xpress has established an innovative flowchart to characterize the glycosylation profile of any protein of interest, including antibodies.
